Forecast Ledgerinterventional psychiatry and psychedelic medicineQuoted, dated predictions scored against public outcomes under one written method. Every score links to the words, the rule and the evidence.

Not admitted · Commitment (own venture)

Rules 1.1.0 · as of 14 Sep 2026

Quote

Commitment (own venture)

“This is also the first RAMHT meeting with robust, shareable data: finally, top-line phase three data on lysergide D-tartrate, otherwise known as LSD, from Definium’s Emerge study in major depressive disorder and Voyage study in generalized anxiety disorder. For the first time we’ll know what double-blind, randomized controlled trials look like.”
· Rapid Acting Mental Health Treatment Comes to the Big Easy on September 14th · substack post

Author tells RAMHT co-founder Grady Hannah that the upcoming New Orleans meeting will feature Definium's top-line phase 3 LSD (lysergide D-tartrate) data from the Emerge study in MDD and the Voyage study in GAD.

The forecaster's own organization can make the outcome happen by its own decision: clinic openings, product launches, hires, trial starts, filings by their own company. Listed in the commitments table, never scored.